Pierre Heudel, MD
Oncology — Centre Léon Bérard, France
Pierre Heudel
LeadR Profile
Oncology
Subspecialties: Public Health - Gynecology - Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 188
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Activity of Low Dose Nivolumab in Patients With Advanced Squamous Cell Carcinomas and Other Cancers. cells, carcinoma, squamous cell, neoplasms, sarcoma, nivolumab, therapeutics | Int J Cancer | 2026 | 0 |
| Primary care physician documentation in oncology electronic health records: prognostic marker or immortal-time bias? bias, neoplasms, documentation, survival analysis, electronic health records, physicians, records, therapeutics, physicians, primary care | ESMO Real World Data Digit Oncol | 2026 | 0 |
| Response to letter Re: COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study. vaccines, neoplasms, cohort studies, vaccination, immune checkpoint inhibitors, covid-19 | Eur J Cancer | 2026 | 0 |
| Expanding Skin Cancer Detection: A Training Program With Tele-Dermoscopy Support for Physiotherapists. skin, physical therapists, education, medical, melanoma, neoplasms, dermatology, skin neoplasms, dermoscopy | Int J Dermatol | 2026 | 0 |
| Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception. safety, vaccines, breast neoplasms, niacinamide, neoplasms, chemoprevention, aspirin, immune checkpoint inhibitors, breast, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, metformin | Cancer Treat Rev | 2026 | 0 |
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Facilitate and Sustain Return to Work After Breast Cancer NCT04846972 — depression, radiotherapy, exercise, psychology, social, quality of life, psychology, breast neoplasms, occupational health, self efficacy, neoplasms, rehabilitation, drug therapy, employment, breast, work, return to work, therapeutics, chemotherapy, women | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map